1. Home
  2. FTFT vs INBS Comparison

FTFT vs INBS Comparison

Compare FTFT & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

HOLD

Current Price

$1.16

Market Cap

6.2M

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.73

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTFT
INBS
Founded
N/A
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.7M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
FTFT
INBS
Price
$1.16
$2.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.1K
47.3K
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.65
EPS
N/A
N/A
Revenue
$3,829,805.00
$1,980,484.00
Revenue This Year
N/A
$778.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
77.46
N/A
52 Week Low
$0.56
$0.54
52 Week High
$4.03
$24.90

Technical Indicators

Market Signals
Indicator
FTFT
INBS
Relative Strength Index (RSI) 37.33 30.26
Support Level $1.02 $1.49
Resistance Level $1.32 $7.25
Average True Range (ATR) 0.11 0.33
MACD -0.00 0.05
Stochastic Oscillator 11.98 11.73

Price Performance

Historical Comparison
FTFT
INBS

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: